دورية أكاديمية
SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024.
| العنوان: | SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024. |
|---|---|
| المؤلفون: | Alghamdi AS; Department of Medicine, Gastroenterology Unit, King Fahad Hospital, Jeddah, Saudi Arabia., Alghamdi H; Hepatology Section, Hepatobiliary Sciences and Organs Transplant Center, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alserehi HA; General Directorate of Communicable Diseases, Ministry of Health, Riyadh, Saudi Arabia., Babatin MA; Department of Medicine, Gastroenterology Unit, King Fahad Hospital, Jeddah, Saudi Arabia., Alswat KA; Liver Disease Research Center, and Riyadh, Saudi Arabia.; College of Medicine, King Saud University, Riyadh, Saudi Arabia., Alghamdi M; Department of Medicine, Division of Gastroenterology, King Fahd Military Complex, Dhahran, Saudi Arabia., AlQutub A; Department of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia., Abaalkhail F; Department of Medicine, Section of Gastroenterology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.; College of Medicine, Al Faisal University, Riyadh, Saudi Arabia., Altraif I; Hepatology Section, Hepatobiliary Sciences and Organs Transplant Center, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alfaleh FZ; Liver Disease Research Center, and Riyadh, Saudi Arabia., Sanai FM; Liver Disease Research Center, and Riyadh, Saudi Arabia.; Gastroenterology Section, Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia. |
| المصدر: | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association [Saudi J Gastroenterol] 2024 Jan 01; Vol. 30 (Supp 1), pp. S1-S42. Date of Electronic Publication: 2024 Jan 03. |
| نوع المنشور: | Review; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Medknow Publications Country of Publication: India NLM ID: 9516979 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1998-4049 (Electronic) Linking ISSN: 13193767 NLM ISO Abbreviation: Saudi J Gastroenterol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2010-> : Mumbai : Medknow Publications Original Publication: Riyadh : Saudi Gastroenterology Association, c1995- |
| مواضيع طبية MeSH: | Hepatitis C*/diagnosis , Hepatitis C*/drug therapy , Hepatitis C*/epidemiology , Liver Transplantation* , Liver Neoplasms* , Hepatitis C, Chronic*/diagnosis , Hepatitis C, Chronic*/drug therapy , Hepatitis C, Chronic*/epidemiology, Humans ; Hepacivirus ; Risk Factors ; Antiviral Agents/therapeutic use |
| مستخلص: | Abstract: Hepatitis C virus (HCV) infection has been a major global health concern, with a significant impact on public health. In recent years, there have been remarkable advancements in our understanding of HCV and the development of novel therapeutic agents. The Saudi Society for the Study of Liver Disease and Transplantation formed a working group to develop HCV practice guidelines in Saudi Arabia. The methodology used to create these guidelines involved a comprehensive review of available evidence, local data, and major international practice guidelines regarding HCV management. This updated guideline encompasses critical aspects of HCV care, including screening and diagnosis, assessing the severity of liver disease, and treatment strategies. The aim of this updated guideline is to assist healthcare providers in the management of HCV in Saudi Arabia. It summarizes the latest local studies on HCV epidemiology, significant changes in virus prevalence, and the importance of universal screening, particularly among high-risk populations. Moreover, it discusses the promising potential for HCV elimination as a public health threat by 2030, driven by effective treatment and comprehensive prevention strategies. This guideline also highlights evolving recommendations for advancing disease management, including the treatment of HCV patients with decompensated cirrhosis, treatment of those who have previously failed treatment with the newer medications, management in the context of liver transplantation and hepatocellular carcinoma, and treatment for special populations. (Copyright © 2023 Copyright: © 2023 Saudi Journal of Gastroenterology.) |
| References: | J Viral Hepat. 2019 Mar;26(3):337-349. (PMID: 30421537) Teratology. 1978 Feb;17(1):93-101. (PMID: 415379) N Engl J Med. 2015 Aug 20;373(8):714-25. (PMID: 26196502) J Hepatol. 2017 Jan;66(1):39-47. (PMID: 27622858) Clin Gastroenterol Hepatol. 2018 Mar;16(3):417-426. (PMID: 28951228) Saudi J Gastroenterol. 2016 Jul-Aug;22(4):269-81. (PMID: 27488321) Scand J Gastroenterol. 2009;44(12):1487-90. (PMID: 19900055) Viruses. 2023 Sep 29;15(10):. (PMID: 37896803) Antivir Ther. 2019;24(1):35-44. (PMID: 30382942) J Clin Gastroenterol. 2018 May/Jun;52(5):452-457. (PMID: 28767462) J Hepatol. 2013 Oct;59(4):675-83. (PMID: 23712051) J Hepatol. 2022 Apr;76(4):959-974. (PMID: 35120736) Aliment Pharmacol Ther. 2019 Jan;49(1):99-106. (PMID: 30467877) PLoS One. 2020 May 20;15(5):e0233446. (PMID: 32433676) Gastroenterology. 2017 Jul;153(1):113-122. (PMID: 28390869) J Gastroenterol. 2018 Apr;53(4):557-565. (PMID: 28948366) Am J Gastroenterol. 2019 Sep;114(9):1550-1552. (PMID: 31082871) Hepatology. 2006 Jan;43(1):100-7. (PMID: 16323213) Infect Dis Ther. 2022 Aug;11(4):1661-1682. (PMID: 35749010) J Hepatol. 2019 Oct;71(4):660-665. (PMID: 31195062) Lancet. 2015 Oct 17;386(10003):1537-45. (PMID: 26456905) Am J Hematol. 2019 Feb;94(2):E43-E45. (PMID: 30394575) J Hepatol. 2017 Jul;67(1):32-39. (PMID: 28267622) Infect Dis Ther. 2023 Jul;12(7):1849-1860. (PMID: 37329414) Hepatology. 2018 Oct;68(4):1298-1307. (PMID: 29672891) Ann Hepatol. 2021 Jul-Aug;23:100268. (PMID: 33059055) Hepatology. 2020 Jul;72(1):7-18. (PMID: 31652357) Lancet Gastroenterol Hepatol. 2018 Mar;3(3):172-180. (PMID: 29371017) Virol J. 2019 Mar 14;16(1):34. (PMID: 30871566) Saudi J Gastroenterol. 2007 Jul-Sep;13(3):147-9. (PMID: 19858635) Lancet. 2019 Apr 6;393(10179):1453-1464. (PMID: 30765123) Drug Metab Dispos. 2018 Aug;46(8):1212-1225. (PMID: 29695614) Adv Ther. 2022 Jul;39(7):3146-3158. (PMID: 35543964) Infect Drug Resist. 2021 Jan 18;14:111-117. (PMID: 33500633) Liver Int. 2019 Jun;39(6):1033-1043. (PMID: 30636361) N Engl J Med. 2015 Dec 31;373(27):2599-607. (PMID: 26571066) Open Forum Infect Dis. 2021 Jun 09;8(7):ofab267. (PMID: 34337093) Clin Res Hepatol Gastroenterol. 2017 Feb;41(1):39-45. (PMID: 27542514) Ann Saudi Med. 2013 Jan-Feb;33(1):10-2. (PMID: 23458933) J Hepatol. 2017 Dec;67(6):1204-1212. (PMID: 28802876) Hepatology. 2016 May;63(5):1493-505. (PMID: 26754432) Am J Transplant. 2016 May;16(5):1588-95. (PMID: 26604182) Lancet Gastroenterol Hepatol. 2020 Oct;5(10):918-926. (PMID: 32531259) Front Pharmacol. 2023 May 12;14:1170039. (PMID: 37251345) Clin Gastroenterol Hepatol. 2023 Feb;21(2):424-434.e5. (PMID: 35131346) J Hepatol. 2020 Jun;72(6):1112-1121. (PMID: 32061651) Diagnostics (Basel). 2022 May 18;12(5):. (PMID: 35626411) Liver Int. 2020 Mar;40(3):522-529. (PMID: 31815353) Liver Int. 2016 Jul;36(7):971-6. (PMID: 26786792) Ann Med. 2022 Dec;54(1):108-120. (PMID: 34969349) Liver Int. 2020 Oct;40(10):2385-2393. (PMID: 32445613) Clin Liver Dis (Hoboken). 2023 Sep 18;22(4):134-139. (PMID: 37908870) J Hepatol. 2018 Sep;69(3):603-607. (PMID: 29886154) J Hepatol. 2019 Jan;70(1):15-23. (PMID: 30266283) Lancet Gastroenterol Hepatol. 2020 Sep;5(9):839-849. (PMID: 32682494) Lancet Gastroenterol Hepatol. 2018 Aug;3(8):559-565. (PMID: 29859740) BMC Infect Dis. 2022 Jan 27;22(1):94. (PMID: 35086481) Hepatology. 2015 Jan;61(1):41-5. (PMID: 25314116) Hepatology. 2009 Oct;50(4):1056-63. (PMID: 19670415) Gastroenterology. 2021 Apr;160(5):1502-1520.e1. (PMID: 33529675) J Gastroenterol. 2019 Aug;54(8):752-761. (PMID: 30868245) Hepatology. 2018 Mar;67(3):837-846. (PMID: 29059461) J Gastroenterol Hepatol. 2007 Apr;22(4):515-7. (PMID: 17376043) Clin Gastroenterol Hepatol. 2019 Feb;17(3):527-535.e6. (PMID: 30012435) J Clin Med. 2020 Feb 19;9(2):. (PMID: 32092892) World J Hepatol. 2022 Jun 27;14(6):1248-1257. (PMID: 35978662) Clin Infect Dis. 2023 Feb 8;76(3):e607-e612. (PMID: 36004410) Ann Intern Med. 2017 Jun 06;166(11):792-798. (PMID: 28437794) Gastroenterology. 2019 Dec;157(6):1506-1517.e1. (PMID: 31401140) J Hepatol. 2020 Dec;73(6):1368-1378. (PMID: 32707225) Hepatology. 2018 Apr;67(4):1253-1260. (PMID: 29152781) Hepatology. 2014 Jan;59(1):318-27. (PMID: 24115039) Clin Gastroenterol Hepatol. 2017 Jan;15(1):132-136. (PMID: 27392759) J Hepatol. 2021 Oct;75(4):829-839. (PMID: 34023350) Hepatology. 2018 Oct;68(4):1277-1287. (PMID: 29633389) Clin Microbiol Infect. 2019 Mar;25(3):365-371. (PMID: 29906601) J Hepatol. 2016 Sep;65(3):524-31. (PMID: 27212241) Liver Int. 2016 Jun;36(6):807-16. (PMID: 26923436) Br J Cancer. 2005 Feb 14;92(3):607-12. (PMID: 15685242) Gastroenterology. 2008 Apr;134(4):960-74. (PMID: 18395077) Health Sci Rep. 2022 Dec 08;6(1):e980. (PMID: 36514327) J Epidemiol Community Health. 2010 Nov;64(11):989-97. (PMID: 19822552) Ann Intern Med. 2013 Jun 4;158(11):807-20. (PMID: 23732714) Transpl Int. 2016 Sep;29(9):999-1007. (PMID: 27203857) J Hepatol. 2019 Mar;70(3):379-387. (PMID: 30472321) Clin Microbiol Infect. 2017 Apr;23(4):267.e1-267.e4. (PMID: 27956268) J Formos Med Assoc. 2021 Feb;120(2):794-803. (PMID: 32861550) Lancet Gastroenterol Hepatol. 2022 Jun;7(6):533-541. (PMID: 35248213) Hepatol Int. 2023 Oct;17(5):1150-1161. (PMID: 37273170) J Hepatol. 2018 May;68(5):895-903. (PMID: 29221887) N Engl J Med. 2017 Jun 1;376(22):2134-2146. (PMID: 28564569) J Hepatol. 2017 May;66(5):910-918. (PMID: 28108232) Ann Hepatol. 2019 May - Jun;18(3):434-438. (PMID: 31023614) Saudi J Kidney Dis Transpl. 2003 Oct-Dec;14(4):442-50. (PMID: 17657114) JHEP Rep. 2022 Dec 16;5(3):100650. (PMID: 36852107) J Hepatol. 2023 Aug;79(2):314-320. (PMID: 37088312) J Hepatol. 2021 May;74(5):1053-1063. (PMID: 33242501) J Viral Hepat. 2021 Nov;28(11):1635-1642. (PMID: 34448313) J Hepatol. 2019 May;70(5):1019-1023. (PMID: 30857780) Liver Transpl. 2016 Nov;22(11):1536-1543. (PMID: 27543748) Infect Dis Ther. 2022 Feb;11(1):485-500. (PMID: 34967920) Hepatology. 2014 Mar;59(3):767-75. (PMID: 24436062) Gastroenterology. 2018 Mar;154(4):989-997. (PMID: 29174546) Saudi J Gastroenterol. 2021 May-Jun;27(3):115-126. (PMID: 33976009) Gut Liver. 2020 May 15;14(3):357-367. (PMID: 30970444) Arab J Gastroenterol. 2021 Dec;22(4):285-291. (PMID: 34531135) Clin Gastroenterol Hepatol. 2006 May;4(5):645-52. (PMID: 16630770) Hepatology. 2018 Feb;67(2):514-523. (PMID: 28926120) Ann Gastroenterol. 2020 May-Jun;33(3):293-298. (PMID: 32382233) Lancet Gastroenterol Hepatol. 2019 Feb;4(2):127-134. (PMID: 30555048) J Hepatol. 2020 Mar;72(3):441-449. (PMID: 31682879) Kidney Int. 2004 Jun;65(6):2335-42. (PMID: 15149347) N Engl J Med. 2017 Sep 14;377(11):1105. (PMID: 28902585) Gastroenterology. 2018 Oct;155(4):1120-1127.e4. (PMID: 29958855) N Engl J Med. 2015 Dec 31;373(27):2608-17. (PMID: 26575258) J Clin Med. 2021 Apr 15;10(8):. (PMID: 33920785) JHEP Rep. 2023 Jul 27;5(10):100867. (PMID: 37771545) Hepatology. 2017 Jul;66(1):27-36. (PMID: 28240789) J Viral Hepat. 2020 Sep;27(9):886-895. (PMID: 32358826) J Hepatol. 2020 Nov;73(5):1170-1218. (PMID: 32956768) J Hepatol. 2019 Sep;71(3):498-504. (PMID: 31173815) J Viral Hepat. 2020 Oct;27(10):964-973. (PMID: 32436335) Clin Gastroenterol Hepatol. 2021 Nov;19(11):2389-2397.e2. (PMID: 32971230) Hepatology. 2014 Jan;59(1):109-20. (PMID: 23908124) Expert Opin Drug Metab Toxicol. 2017 Sep;13(9):1015-1022. (PMID: 28753040) Liver Int. 2021 Jul;41(7):1518-1522. (PMID: 33966349) Lancet Gastroenterol Hepatol. 2018 Dec;3(12):856-864. (PMID: 30274834) Aliment Pharmacol Ther. 2019 Apr;49(8):1052-1059. (PMID: 30874328) Clin Infect Dis. 2013 Apr;56(7):1038-43. (PMID: 23264364) Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):596-606. (PMID: 23817323) J Viral Hepat. 2018 Jul;25(7):791-801. (PMID: 29406608) Hepatology. 2018 Feb;67(2):600-611. (PMID: 28859220) Liver Int. 2020 May;40(5):1062-1068. (PMID: 31876354) J Hepatol. 2007 Mar;46(3):459-65. (PMID: 17196700) J Infect Public Health. 2019 Sep - Oct;12(5):608-614. (PMID: 31248815) Clin Gastroenterol Hepatol. 2015 Apr;13(4):772-9.e1-3. (PMID: 25528010) Am J Transplant. 2020 Feb;20(2):600-605. (PMID: 31448549) N Engl J Med. 2015 Dec 31;373(27):2618-28. (PMID: 26569658) Aliment Pharmacol Ther. 2019 Mar;49(5):492-505. (PMID: 30687952) Hepatol Commun. 2017 Apr 18;1(3):248-255. (PMID: 29404457) J Hepatol. 2017 Aug;67(2):263-271. (PMID: 28412293) Aliment Pharmacol Ther. 2018 Jun;47(12):1690-1698. (PMID: 29665069) Hepatology. 2011 Jun;53(6):1839-45. (PMID: 21425314) J Viral Hepat. 2019 Mar;26(3):316-322. (PMID: 30380166) Hepatology. 2022 Jul;76(1):139-154. (PMID: 35030279) Int J Infect Dis. 2006 Jul;10(4):272-7. (PMID: 16564719) Clin Infect Dis. 2021 Nov 2;73(9):e3296-e3299. (PMID: 32887999) Clin Infect Dis. 2018 Sep 14;67(7):1010-1017. (PMID: 29566246) Hepatology. 2015 Apr;61(4):1127-35. (PMID: 25614962) J Viral Hepat. 2001 Mar;8(2):87-95. (PMID: 11264728) Ann Saudi Med. 2014 May-Jun;34(3):207-10. (PMID: 25266179) Lancet Gastroenterol Hepatol. 2019 Jan;4(1):45-51. (PMID: 30393106) Clin Gastroenterol Hepatol. 2018 Jan;16(1):27-38.e4. (PMID: 28479504) Pak J Med Sci. 2021 Nov-Dec;37(7):2014-2019. (PMID: 34912436) J Hepatol. 2022 Nov;77(5):1256-1264. (PMID: 35643203) Viruses. 2022 Nov 11;14(11):. (PMID: 36423102) Clin Infect Dis. 2020 Aug 22;71(5):1248-1254. (PMID: 31562816) Eur J Haematol. 2013 Jun;90(6):501-7. (PMID: 23414443) Nephrol Dial Transplant. 2021 Sep 27;36(10):1867-1871. (PMID: 33097949) Hepatology. 2015 Sep;62(3):932-54. (PMID: 26111063) Lancet. 1995 Feb 4;345(8945):289-91. (PMID: 7530793) J Antimicrob Chemother. 2023 Oct 3;78(10):2591-2596. (PMID: 37671831) Am J Kidney Dis. 2023 Oct;82(4):410-418. (PMID: 37061019) Lancet Microbe. 2020 Sep;1(5):e200-e208. (PMID: 32939459) J Viral Hepat. 2020 Apr;27(4):371-375. (PMID: 31756019) Hepatology. 2016 Feb;63(2):408-17. (PMID: 26474537) J Hepatol. 2016 Oct;65(1 Suppl):S33-S45. (PMID: 27641987) Gastroenterol Hepatol (N Y). 2017 Apr;13(4):214-220. (PMID: 28546792) Hepatology. 2017 Jul;66(1):13-26. (PMID: 28195337) Saudi J Gastroenterol. 2020 Oct;26(Suppl 1):S1-S40. (PMID: 33078723) Aliment Pharmacol Ther. 2018 May;47(9):1288-1295. (PMID: 29536554) Hepatology. 2013 Aug;58(2):538-45. (PMID: 23505059) Gastroenterology. 2016 Oct;151(4):651-659.e1. (PMID: 27456384) Gastroenterology Res. 2018 Apr;11(2):124-129. (PMID: 29707079) J Am Soc Nephrol. 2007 May;18(5):1584-93. (PMID: 17429053) Diabetes Care. 2017 Sep;40(9):1173-1180. (PMID: 28659309) Hepatol Int. 2023 Jun;17(3):550-561. (PMID: 36973633) Clin Infect Dis. 2017 Jun 15;64(12):1711-1720. (PMID: 28199525) Clin Infect Dis. 2016 Jun 15;62(12):1489-96. (PMID: 27025835) J Viral Hepat. 2023 Sep;30(9):740-745. (PMID: 37260083) Hepatology. 2018 Apr;67(4):1560-1599. (PMID: 29405329) N Engl J Med. 2014 Jan 16;370(3):211-21. (PMID: 24428467) Liver Int. 2020 May;40(5):1032-1041. (PMID: 31821716) J Formos Med Assoc. 2019 May;118(5):907-913. (PMID: 30316677) Hepatol Res. 2011 Apr;41(4):328-39. (PMID: 21426450) J Hepatol. 2019 Oct;71(4):666-672. (PMID: 31203153) J Leukoc Biol. 2008 Oct;84(4):988-93. (PMID: 18515327) Viruses. 2022 Dec 31;15(1):. (PMID: 36680177) J Hepatol. 2015 Jul;63(1):237-64. (PMID: 25911335) Lancet Infect Dis. 2017 Oct;17(10):1062-1068. (PMID: 28818546) Aliment Pharmacol Ther. 2018 Jan;47(1):104-113. (PMID: 29035002) N Engl J Med. 2017 Oct 12;377(15):1448-1455. (PMID: 29020583) Saudi J Gastroenterol. 2012 Nov-Dec;18(6):349-57. (PMID: 23150019) Aliment Pharmacol Ther. 2020 Jan;51(1):34-52. (PMID: 31808566) Aliment Pharmacol Ther. 2017 Oct;46(7):688-695. (PMID: 28791711) Rev Esp Quimioter. 2019 Apr;32(2):137-144. (PMID: 30761823) Saudi J Gastroenterol. 2015 Mar-Apr;21(2):60-3. (PMID: 25843190) Hepatology. 2018 Feb;67(2):492-504. (PMID: 28873225) Liver Int. 2020 Aug;40(8):1841-1852. (PMID: 32449966) J Formos Med Assoc. 2022 Nov;121(11):2265-2272. (PMID: 35581112) Hepatology. 2018 Feb;67(2):505-513. (PMID: 28865152) Hepatology. 2016 May;63(5):1430-41. (PMID: 26822022) Aliment Pharmacol Ther. 2020 Jul;52(1):168-181. (PMID: 32441382) Clin Microbiol Infect. 2016 May;22(5):459.e1-6. (PMID: 26806260) Hepatology. 2003 Aug;38(2):518-26. (PMID: 12883497) Clin Gastroenterol Hepatol. 2022 May;20(5):1151-1162.e6. (PMID: 34333150) Gastroenterology. 2017 Jan;152(1):142-156.e2. (PMID: 27641509) |
| المشرفين على المادة: | 0 (Antiviral Agents) |
| تواريخ الأحداث: | Date Created: 20240103 Date Completed: 20240105 Latest Revision: 20240211 |
| رمز التحديث: | 20240211 |
| مُعرف محوري في PubMed: | PMC10856511 |
| DOI: | 10.4103/sjg.sjg_333_23 |
| PMID: | 38167232 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1998-4049 |
|---|---|
| DOI: | 10.4103/sjg.sjg_333_23 |